A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery-Reference-Cited by-同舟云学术

A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery

Published:2022-11 Issue: Volume:176 Page:155-163
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Rosenbaum Evan^ORCID,Chugh Rashmi,Ryan Christopher W.,Agulnik Mark^ORCID,Milhem Mohammed M.,George Suzanne,Jones Robin L.^ORCID,Chmielowski Bartosz^ORCID,Van Tine Brian A.,Tawbi Hussein,Elias Anthony D.^ORCID,Read William L.,Budd G. Thomas,Qin Li-Xuan,Rodler Eve T.,Hirman Joe,Weiden Paul,Bennett Cathryn M.,Livingston Philip O.,Ragupathi Govind,Hansen David,D'Angelo Sandra P.,Tap William D.,Schwartz Gary K.,Maki Robert G.^ORCID,Carvajal Richard D.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Cancer statistics, 2021;Siegel;CA A Cancer J Clin,2021

2. Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial;Tap;JAMA,2020

3. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma;Tan;Ann Surg,2016

4. Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma;Billingsley;Cancer,1999

5. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival;Billingsley;Ann Surg,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment;Biomaterials;2025-01

2. Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Bioactive sphingolipids as emerging targets for signal transduction in cancer development;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics;Life Sciences;2024-08

5. GD2-targeting therapy: a comparative analysis of approaches and promising directions;Frontiers in Immunology;2024-03-15